Eric A Adams - Net Worth and Insider Trading

Eric A Adams Net Worth

The estimated net worth of Eric A Adams is at least $9,930 dollars as of 2024-06-10. Eric A Adams is the President & CEO of InMed Pharmaceuticals Inc and owns about 43,959 shares of InMed Pharmaceuticals Inc (INM) stock worth over $9,930. Details can be seen in Eric A Adams's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eric A Adams has not made any transactions after 2024-02-20 and currently still holds the listed stock(s).

Transaction Summary of Eric A Adams

To

Eric A Adams Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric A Adams owns 1 companies in total, including InMed Pharmaceuticals Inc (INM) .

Click here to see the complete history of Eric A Adams’s form 4 insider trades.

Insider Ownership Summary of Eric A Adams

Ticker Comapny Transaction Date Type of Owner
INM InMed Pharmaceuticals Inc 2024-02-20 director & President & CEO

Eric A Adams Latest Holdings Summary

Eric A Adams currently owns a total of 1 stock. Eric A Adams owns 43,959 shares of InMed Pharmaceuticals Inc (INM) as of February 20, 2024, with a value of $9,930.

Latest Holdings of Eric A Adams

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INM InMed Pharmaceuticals Inc 2024-02-20 43,959 0.23 9,930

Holding Weightings of Eric A Adams


Eric A Adams Form 4 Trading Tracker

According to the SEC Form 4 filings, Eric A Adams has made a total of 5 transactions in InMed Pharmaceuticals Inc (INM) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in InMed Pharmaceuticals Inc is the acquisition of 41,600 shares on February 20, 2024, which cost Eric A Adams around $14,976.

Insider Trading History of Eric A Adams

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eric A Adams Trading Performance

GuruFocus tracks the stock performance after each of Eric A Adams's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric A Adams is -33.76%. GuruFocus also compares Eric A Adams's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric A Adams within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eric A Adams's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eric A Adams

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -8.99 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -8.66 LIMIT LIMIT LIMIT LIMIT LIMIT

Eric A Adams Ownership Network

Ownership Network List of Eric A Adams

No Data

Ownership Network Relation of Eric A Adams

Insider Network Chart

Eric A Adams Owned Company Details

What does InMed Pharmaceuticals Inc do?

Who are the key executives at InMed Pharmaceuticals Inc?

Eric A Adams is the director & President & CEO of InMed Pharmaceuticals Inc. Other key executives at InMed Pharmaceuticals Inc include Interim CFO Jonathan Tegge , VP & Accounting and Controller Sarah Li , and Interim CFO Brenda Edwards .

InMed Pharmaceuticals Inc (INM) Insider Trades Summary

Over the past 18 months, Eric A Adams made 1 insider transaction in InMed Pharmaceuticals Inc (INM) with a net purchase of 41,600. Other recent insider transactions involving InMed Pharmaceuticals Inc (INM) include a net purchase of 37,500 shares made by Andrew Hull ,

In summary, during the past 3 months, insiders sold 0 shares of InMed Pharmaceuticals Inc (INM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of InMed Pharmaceuticals Inc (INM) were sold and 79,100 shares were bought by its insiders, resulting in a net purchase of 79,100 shares.

InMed Pharmaceuticals Inc (INM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

InMed Pharmaceuticals Inc Insider Transactions

No Available Data

Eric A Adams Mailing Address

Above is the net worth, insider trading, and ownership report for Eric A Adams. You might contact Eric A Adams via mailing address: C/o Inmed Pharmaceuticals Inc., Suite 310 - 815 Hastings Street, Vancouver A1 V6c 1b4.

Discussions on Eric A Adams

No discussions yet.